載入...
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Advances and Treatment Strategies in the First-Line Setting
The treatment landscape of metastatic hormone-sensitive prostate cancer (mHSPC) has changed radically in recent years. Androgen deprivation therapy (ADT) alone was for decades the standard of care for treating mHSPC. This changed when studies showed that the addition of docetaxel chemotherapy or abi...
Na minha lista:
| 發表在: | Oncol Ther |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Healthcare
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7683690/ https://ncbi.nlm.nih.gov/pubmed/32700045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40487-020-00119-z |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|